Member Info for ogm4

Sanofi to pay $600M upfront for Dren Bio antibody

Indeed according to the CEO we can expect news on multiple fronts.

GM all, a bit more of meat on the bone will slowly start to jack up the market cap to more sensible levels. This is a unique opportunity in terms of risk and reward.

Another interview today this time with Zak Mir:

https://zakstraderscafe.com/interview-tim-mccarthy-ceo-immupharma/11086/

1 hr

Tim McCarthy, CEO of #IMM talks to Zak Mir, 'Traders Cafe' on the UK biotech arena as a public company with 2 key scientific announcements issued by #IMM over the last period & details on the #MOA of #IMMs P140 auto-immune technology platform

https://x.com/ImmuPharma/status/1901625555981668819

Indeed a number of block trades showing up today.

I suspect both interviews were recorded last week.

Proactive normally comes out couple of days later, could be tomorrow or on Wednesday. Or he skipped it as he had to pack his bag for the Italy bio conference this week.

As he said "extremely busy times for the company" currently.

For those who haven't listened to the interview yet, I strongly suggest you do as there were many new insights imo

I expect today to be a bit blue tbh after yesterday's new interview out.

IMM's PR machine slowly starting to fire on all cylinders!

Thanks Hosko for the link!

May I suggest everyone who is even slightly interested has a good listen to this new interview with CEO Tim McCarthy just being released.

Interview starting 20:05 mins in:

https://www.thesundayroast.net/podcast/episode/510083b0/s9-ep71-sunday-roast-podcast-featuring-tim-mccarthy-ceo-immupharma-che-connon-ceo-and-geoff-baker-executive-director-bsf-enterprise-and-charles-bray-chairman-aterian-or-stock-discussion-on-imm-bsfa-atn-cpai-atm-tun-xtr-bzt-glr-afp-gmet-ggp

CEO's interview - mind blowing!...:

"We have proven for the first time our hypothesis"

"This is the massive breakthrough..."

"This is the first definitive proof through pre-clinical studies..."

"This is the key to open the door"

"We've been talking with major pharma companies for a little while now, they're all VERY, VERY interested..."

.....

tbc

Again great PR by the company whilst part of the board incl. TimMcC CEO will be in Italy over the next few days further expanding the business case for the P140 platform as a showcase to the rest of the pharma industry.

I guess the PR machine has started really rolling now!...

I suspect it was a £40k buy at 4.128p straight after the RNS on Thursday morning.

"These results are extremely compelling. Not only do they validate our MOA, they also indicate that P140 has the possibility to become a central treatment for a number of autoimmune diseases. Patients can be very hopeful, I certainly am!"

This potentially has so much more leverage for during the current ongoing discussions with potential JV or takeover partners. P140 could become a major central platform of strong interest. Majors are typically even more interested in integrated solutions. This would give them huge advantage over competitors.

I like the sound of this:

"...our objective to secure the optimum deal(s) for our shareholders.""

Remember Tim said earlier in one of the videos there will be a few surprises here and there. Who knows could be a different company than Avion. We'll find out shortly.

These discoveries result from a new preclinical study designed by ImmuPharma Biotech's team and conducted at a "world leading Laboratory" in the USA.

Do they mean Avion or a different company here?

Importance of Mechanism Of Action (MOA) as used in the pharmaceutical industry:

https://en.m.wikipedia.org/wiki/Mechanism_of_action

Indeed and bear in mind they first have to get all the patents sorted before disclosing any sensitive information to the public. Plus NDA's with potential partners.

Curious to watch the next video!

https://x.com/proactive_UK/status/1900110603764527526